RIL
ABMD

Rothschild Investment LLC’s Abiomed Inc ABMD Stock Holding History

Rothschild Investment LLC’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,505
Closed -$480K – 498
2021
Q1 		$480K Sell
1,505
-45
-3% -$14.4K 0.04% 316
2020
Q4 		$503K Hold
1,550
– – 0.05% 284
2020
Q3 		$429K Hold
1,550
– – 0.05% 283
2020
Q2 		$374K Hold
1,550
– – 0.05% 284
2020
Q1 		$225K Buy
+1,550
New +$257K 0.03% 353

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Rothschild Investment LLC's ABMD Position: Q2 2021 in Review

Rothschild Investment LLC sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 1,505 shares — an estimated $480K sold.

Rothschild Investment LLC first reported a position in ABMD in Q1 2020 and held it in 5 quarters. The position peaked at $503K in Q4 2020. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Rothschild Investment LLC reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Rothschild Investment LLC sold 1,505 Abiomed Inc shares in Q2 2021, an estimated $480K.
  • Rothschild Investment LLC first reported a position in Abiomed Inc in Q1 2020 and held it in 5 quarters.
  • Rothschild Investment LLC's Abiomed Inc position peaked at $503K in Q4 2020.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Rothschild Investment LLC's 13F filing for Q2 2021, filed 19 Jul 2021.